Now showing items 1-20 of 21

    Issue DateTitleAuthor(s)
    26 April 2020Capsaicin-induced changes in electrical pain perception threshold can be used to assess the magnitude of secondary hyperalgesia in humans  Hughes, SW; Basra, M; Chan, C; et al.
    1 June 2023Cardiopulmonary exercise testing provides prognostic information in advanced cystic fibrosis lung disease  Radtke, T; Urquhart, DS; Braun, J; et al.
    25 October 2023Cardiopulmonary exercise testing provides prognostic information in advanced cystic fibrosis lung disease  Radtke, T; Urquhart, DS; Braun, J; et al.
    22 January 2023Causal effects of maternal circulating amino acids on offspring birthweight: a Mendelian randomisation study  Zhao, J; Stewart, ID; Baird, D; et al.
    26 January 2023Cholelithiasis is an additional pre-pregnancy clinical risk factor for preeclampsia (dataset)  Arbuzova, S; Nikolenko, M; Wright, D; et al.
    11 April 2024Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements  Laver, TW; Wakeling, MN; Caswell, RC; et al.
    25 August 2023Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk.  Edsfeldt, A; Gonçalves, I; Vigren, I; et al.
    22 January 2024Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study  Jones, AG; Shields, BM; Oram, RA; et al.
    23 December 2023Comment on a recent article titled 'Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia'  Clissold, R; Bingham, C; Hattersley, A
    7 August 2023Common pathogenesis of early and late preeclampsia – evidence from recurrences (dataset)  Arbuzova, S
    5 January 2024Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme  Sabatini, S; Martyr, A; Hunt, A; et al.
    24 September 2022Comparative adherence and persistence of single- and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in an English real-world primary care setting  Halpin, DMG; Rothnie, KJ; Banks, V; et al.
    20 July 2022Comparative efficacy of Umeclidinium/Vilanterol versus other bronchodilators for the treatment of chronic obstructive pulmonary disease: A network meta-analysis  Ismaila, AS; Haeussler, K; Czira, A; et al.
    4 June 2024Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young  Cardoso, P; McDonald, TJ; Patel, KA; et al.
    16 June 2023Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: An application for type 2 diabetes precision medicine  Venkatasubramaniam, A; Mateen, BA; Shields, BM; et al.
    11 November 2022Comparison of percent predicted and percentile values for VO2max in people with interstitial lung disease  Kranen, SH; Tomlinson, OW; Williams, CA; et al.
    3 November 2023Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer  Mou, Z; Spencer, J; McGrath, JS; et al.
    21 April 2022Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study  Niwaha, AJ; Rodgers, LR; Carr, ALJ; et al.
    2 September 2022Correction to: Comparative efficacy of Umeclidinium/Vilanterol versus other bronchodilators for the treatment of chronic obstructive pulmonary disease: A network meta-analysis.  Ismaila, AS; Haeussler, K; Czira, A; et al.
    19 July 2023Cortico-thalamocortical interactions for learning, memory and decision-making  Perry, BAL; Mendez, JC; Mitchell, AS